Cynata Sets Stage For Global Fujifilm Cell Therapy Deal
Executive Summary
Cynata has inched closer to a major global partnership after signing a term sheet with Fujifilm for cell therapy technologies that has been described by analysts as a potentially transformative deal.
You may also be interested in...
Early-Stage Cell And Gene Therapy Progress: Updates From Casebia, BlueRock, Athersys, Cynata
Scrip caught up with several companies during the recent Cell and Gene Meeting on the Mesa, sponsored by the Alliance for Regenerative Medicine.
Fujifilm Promises A Shake-Up Of Regenerative Medicines Market
Fujifilm has successfully transformed its business strategy by expanding away from traditional photographic film and toward new priority business fields – significantly in regenerative medicine. Identifying health care as a key growth area, Fujifilm targets the role of being a comprehensive provider in the fields of prevention, diagnosis and treatment.
Fujifilm, CDI Agree $307m Acquisition
Fujifilm is forking out $307 million for US firm Cellular Dynamics International (CDI) in order to become "more competitive in the field of drug discovery and regenerative medicine," said Fujifilm CEO Shigetaka Komori.